Sourcing Excipients an Ongoing Challenge for Biopharmas, says analyst
Economics mean Biopharmas will continue to struggle to find excipient suppliers in the medium term, says an industry expert.
Archives for July 16, 2013
Uptake of Single-Use Bioreactors Expected to See Massive Growth, Experts Say
As biopharma manufacturers look to save money setting up facilities and cleaning equipment, companies are increasingly turning to single-use technology and especially single-use bioreactors.
EMA Approves First MAb Biosimilars
The European Medicine’s Agency (EMA) has approved the first biosimilar monoclonal antibodies and expects to approve increasingly complex biosimilars as the regulatory framework becomes more flexible.
Editor's blog
Lies of The Planet of The Apes?
Could a genetically engineered adenovirus really spark a simian revolution and make chimps our masters? BioPharma-Reporter.com looks at the ‘science’ of the 2011 movie “Rise of the Planet of the Apes.”
Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.